COMP <GO>
EXPD vs CHRW // GROSS PROFIT MARGIN
Expeditors International of Washington Inc. (NYSE) VS. C.H. Robinson Worldwide Inc. (NASDAQ) • 15-METRIC TALLY: EXPD 9
— CHRW 4
■ METRIC PARITY
LAST: $198.39 (+0.63%) • MKT CAP: $25.79B
gross-margins
—
LAST: $127.43 (-0.13%) • MKT CAP: $14.89B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EXPD VS. CHRW)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EXPD | CHRW | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.30% | 22.60% | +17.70 | EXPD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.3x | 19.5x | -2.20 | EXPD | /valuation <GO> |
| Free Cash Flow Yield | 1.97% | 6.01% | -4.04 | CHRW | /fcf-yield <GO> |
| Operating Margin | 9.50% | 4.90% | +4.60 | EXPD | /operating-margins <GO> |
| Net Profit Margin | 7.30% | 3.60% | +3.70 | EXPD | /net-margins <GO> |
| Revenue Growth (YoY) | 4.40% | -8.40% | +12.80 | EXPD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.80% | 2.02% | -1.22 | CHRW | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.70 | 8.42 | +2.28 | EXPD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | EXPD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.8 | 35.5 | +23.30 | EXPD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.02 | -0.13 | CHRW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.6x | 23.6x | +6.00 | CHRW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $25.79B | $14.89B | $10.90B | EXPD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EXPD REV | CHRW REV | EXPD GROSS % | CHRW GROSS % | EXPD FCF | CHRW FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.07B | $16.23B | — | — | $508.4M | $894.9M |
| FY 2024 | $10.60B | $17.72B | — | — | $246.3M | $486.4M |
| FY 2023 | $9.30B | $17.60B | — | — | $634.7M | -$59.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EXPD // BETA 0.89
CHRW // BETA 1.02